We are live on ! Find out more
KPP

Kings Path Partners Portfolio holdings

AUM $376M
1-Year Est. Return 19%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$376M
AUM Growth
+$90.5M
Cap. Flow
+$62.2M
Cap. Flow %
16.56%
Top 10 Hldgs %
54.62%
Holding
379
New
84
Increased
89
Reduced
55
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 1.84%
2 Energy 1.84%
3 Financials 1.65%
4 Technology 1.51%
5 Industrials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRMD icon
51
iRadimed
IRMD
$1.23B
$654K 0.17%
6,840
CVLG icon
52
Covenant Logistics
CVLG
$1.22B
$649K 0.17%
14,680
+4,039
+38% +$147K
PNTG icon
53
Pennant Group
PNTG
$1.41B
$648K 0.17%
17,550
MCB icon
54
Metropolitan Bank Holding Corp
MCB
$1.22B
$638K 0.17%
6,460
AAPL icon
55
Apple
AAPL
$4.75T
$614K 0.16%
2,121
+691
+48% +$198K
BFST icon
56
Business First Bancshares
BFST
$998M
$608K 0.16%
19,770
WULF icon
57
TeraWulf
WULF
$9.69B
$606K 0.16%
24,535
+13,360
+120% +$307K
UFPT icon
58
UFP Technologies
UFPT
$1.89B
$586K 0.16%
2,210
AGX icon
59
Argan
AGX
$8.48B
$569K 0.15%
713
-1,030
-59% -$685K
TILT icon
60
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.17B
$560K 0.15%
2,030
-5
-0.2% -$1.33K
TFIN icon
61
Triumph Financial Inc
TFIN
$1.84B
$554K 0.15%
+7,255
New +$493K
BNDW icon
62
Vanguard Total World Bond ETF
BNDW
$1.89B
$540K 0.14%
7,876
-5
-0.1% -$341
PAHC icon
63
Phibro Animal Health
PAHC
$1.33B
$539K 0.14%
17,155
GRBK icon
64
Green Brick Partners
GRBK
$3.03B
$536K 0.14%
6,701
ANIP icon
65
ANI Pharmaceuticals
ANIP
$1.76B
$513K 0.14%
6,200
IJH icon
66
iShares Core S&P Mid-Cap ETF
IJH
$122B
$503K 0.13%
6,524
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.05T
$496K 0.13%
991
+36
+4% +$17.3K
PLPC icon
68
Preformed Line Products
PLPC
$1.6B
$474K 0.13%
+1,155
New +$405K
BLFS icon
69
BioLife Solutions
BLFS
$1.42B
$468K 0.12%
16,570
WLDN icon
70
Willdan Group
WLDN
$1.11B
$467K 0.12%
+5,910
New +$503K
SCHR
71
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$450K 0.12%
18,268
-1,175
-6% -$29K
LMAT icon
72
LeMaitre Vascular
LMAT
$2.3B
$449K 0.12%
4,675
-1,445
-24% -$148K
BIL icon
73
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$432K 0.12%
4,718
+393
+9% +$36K
GRDN
74
Guardian Pharmacy Services
GRDN
$2.52B
$431K 0.11%
10,300
TSLA icon
75
Tesla
TSLA
$1.41T
$421K 0.11%
1,000
+500
+100% +$199K

Similar funds

Kings Path Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Kings Path Partners held 379 positions worth $376M, up 32% from $285M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Kings Path Partners deployed $62.2M of net new capital in Q2 2026, opening 84 new positions and adding to 89 existing holdings. Its largest new stake was Tortoise MLP ETF: 147,412 shares worth $4.08M.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, down from 2.2% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Schwab International Equity ETF, an estimated $1.68M trimmed.

  • Kings Path Partners's largest Q2 2026 buy was Tortoise MLP ETF: 147,412 shares worth $4.08M.
  • Kings Path Partners added most to Vanguard Total Stock Market ETF in Q2 2026, an estimated $7.16M increase.
  • Kings Path Partners's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $1.68M.
  • Kings Path Partners fully exited Bluerock Private Real Estate Fund in Q2 2026, selling an estimated $690K.
  • Kings Path Partners's ten largest holdings make up 55% of its $376M portfolio in Q2 2026.
  • Kings Path Partners opened 84 new positions and closed 27 in Q2 2026.
  • Kings Path Partners's portfolio value rose 32% quarter-over-quarter to $376M.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.